SIK2 and renal cell carcinoma: For example, Xu et al. reported that FTO-mediated m6A modification regulates SIK2, a functional target of m6A-mediated autophagy, expression through IGF2BP2-dependent SIK2 mRNA stability, thereby promoting renal cell carcinoma (Xu et al., 2022).